Reports, publications and correspondence

The council produces considered reports that will be helpful to policy makers, practitioners, service providers and others.

Drug specific reports

The Advisory Council carries out in-depth reviews of specific drugs, including their classification under the Misuse of Drugs Act 1971.

The most recent drug specific reports published by the Advisory Council are:

• Desoxypipradrol report (September 2011)
• Consideration of the anabolic steroids (September 2010)
• ACMD Naphyrone Report (July 2010)
• Consideration of the cathinones (March 2010)
• ACMD report on the cannabinoid agonists
• ACMD 1-benzylpiperazine (BZP) Report (2008)
• GBL & 1,4-BD: Assessment of Risk to the Individual and Communities in the UK (2008)
• MDMA (‘ecstasy’): a review of its harms and classification under the Misuse of Drugs Act 1971 (2009)
• Cannabis Classification and Public Health (2008)
• Drug Facilitated Sexual Assault (DFSA) Report (2007)
• Latest Methylamphetamine Recommendation (2006)
• Further consideration of the classification of cannabis under the Misuse of Drugs Act 1971 (2005)
• Khat Report (2005)
• Methylamphetamine Report (2005)
• Methylamphetamine Executive Summary (2005)
• Methylamphetamine Report Annex (2005)
• Ketamine Report (2004)
• The Classification of cannabis under the Misuse of Drugs Act 1971 (2002)

Inquiry reports

The Advisory Council, through its prevention working group, carries out in-depth inquiries into aspects of drug use that are causing particular concern in the UK, with the aim of producing considered Reports that will be helpful to policy makers, practitioners, service providers and others.

These inquiry reports set out a summary of the Advisory Council’s findings and a series of recommendations for Government and others. It is usual for the government to then publish a formal response.

The most recent inquiry reports published by the Advisory Council are:

• Foil report
• Consideration of the anabolic steroids (September 2010)
• Pathways to Problems - a follow-up report
• Primary prevention of Hepatitis C among injecting drug users
• Pathways to Problems: Hazardous use of tobacco, alcohol and other drugs by young people in the UK and its implications for policy (2006)
• Hidden Harm: Responding to the needs of children of problem drug users (2003)
• Reducing drug related deaths (2000)
• Hidden Harm Three Years On: Realities, Challenges and Opportunities (2007)
• Hidden Harm Three Years On: Realities, Challenges and Opportunities: Executive Summary (2007)

Correspondence

• Methoxetamine - letter from ACMD to minister recommending creation of temporary class drug order for methoxetamine (March 2012)
• Letter from Professor Les Iversen to Lord Henley regarding classification of two steroidal substances (February 2012)
• Advice from ACMD to Baroness Browning regarding Phenazepam
• Letter from Professor Les Iversen to James Brokenshire regarding Sativex
• Letter from Professor Les Iverson to Professor Sir John Beddington
• Letter to Home Secretary regarding government priorities (March 2011)
• Statement by Les Iversen in response to the Home Office appointments to the Advisory Council on the Misuse of Drugs
• Letter to minister regarding Sativex
• Letter to minister on temporary banning powers
• ACMD advice on ‘Ivory Wave’
• Khat review: response from Professor Iversen acceding to the request for the revie (October 2010)
• Khat review: letter from James Brokenshire to Professor Iversen requesting a review of khat misuse
• ACMD letter on amineptine - July 2010
• ACMD letter on mixing of medicines in clinical practice - July 2010
• ACMD letter on tapentadol - July 2010
• ACMD letter to the Home Secretary on the government's consultation on GBL and 1,4-butanediol (2009)
• ACMD letter to the Home Secretary on the consideration of Oripavine (2009)
• ACMD letter to Home Secretary - regarding mephedrone and related cathinones (December 2009)
• Home Secretary Letter to ACMD
• ACMD Letter to Home Secretary (ACMD Work Programme)
• Joint DH-HO letter to ACMD (Hepatitis C Report)
• Home Secretary (Alan Johnson) letter to Professor Les Iverson - March 2010 (cocaine)
• ACMD letter to Home Secretary (Alan Johnson) regarding cociane classification - February 2010

Consultation Responses

• ACMD response to proposed amendment to the Misuse of Drugs - Safe Custody - NI- Regulations 1973
• COPSAC consultation ACMD response 2010
• Response to the review of research and development in forensic science 2011
• ACMD response to Sentencing Guidelines Council
• ACMD response to Drug Strategy consultation 2010
• DfT Road Safety Compliance Consultation

Annual reports

Annual reports from the Advisory Council detailing the main issues considered by its committees and working groups. They also include information about the Advisory Council's terms of reference, membership and administration arrangements.

• annual report 2010-2011
• annual report 2009-2010
• annual report 2008-2009
• annual report 2007-2008
• annual report 2006-2007
• annual report 2005-2006
• annual report 2004-2005
• annual report 2003-2004
• biennial report 2001-2003

Miscellaneous

• Statement by Les Iversen in response to the Home Office appointments to the Advisory Council on the Misuse of Drugs
• ACMD report: consideration of the use of multi-criteria decision analysis in drug harm decision making
  

Share |